Shishir Gadam
Direttore Tecnico/Scientifico/R&S presso CARGO THERAPEUTICS, INC.
Patrimonio netto: 538 894 $ in data 30/04/2024
Profilo
Shishir Gadam is currently a Member at Roche Group and the Chief Technical Officer at Cargo Therapeutics, Inc. He previously worked as the VP-Global Cell Therapy Manufacturing Science at Juno Therapeutics, Inc. Gadam holds a doctorate degree from Rensselaer Polytechnic Institute, a graduate degree from West Virginia University, and an undergraduate degree from the University of Mumbai.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
0.07% | 01/03/2024 | 29 480 ( 0.07% ) | 538 894 $ | 30/04/2024 |
Posizioni attive di Shishir Gadam
| Società | Posizione | Inizio |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Precedenti posizioni note di Shishir Gadam
| Società | Posizione | Fine |
|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | - |
Formazione di Shishir Gadam
| Rensselaer Polytechnic Institute | Doctorate Degree |
| West Virginia University | Graduate Degree |
| University of Mumbai | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARGO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
- Borsa valori
- Insiders
- Shishir Gadam